Bicycle Therapeutics Plc (BCYC)
6.51
+0.04
(+0.62%)
USD |
NASDAQ |
Jan 16, 16:00
6.50
-0.01
(-0.15%)
After-Hours: 20:00
Bicycle Therapeutics EPS Diluted (Quarterly): -0.8476 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.1348 |
| Mereo BioPharma Group Plc | -0.0436 |
| Autolus Therapeutics Plc | -0.2955 |
| DBV Technologies SA | -1.207 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -58.75M |
| Revenue (Quarterly) | 11.66M |
| Total Expenses (Quarterly) | 70.41M |
| Enterprise Value | -190.26M |
| Gross Profit Margin (Quarterly) | 85.04% |
| Profit Margin (Quarterly) | -503.7% |
| Earnings Yield | -55.71% |
| Normalized Earnings Yield | -56.40 |